
November 6, 2017 - By Hazel Jackson
Guardian Capital Advisors Lp increased its stake in Mitsubishi Ufj Finl Group In (MTU) by 41.17% based on its latest 2017Q2 regulatory filing with the SEC. Guardian Capital Advisors Lp bought 67,920 shares as the company’s stock declined 7.14% while stock markets rallied. The institutional investor held 232,895 shares of the commercial banks company at the end of 2017Q2, valued at $1.51 million, up from 164,975 at the end of the previous reported quarter. Guardian Capital Advisors Lp who had been investing in Mitsubishi Ufj Finl Group In for a number of months, seems to be bullish on the $93.63 billion market cap company. The stock declined 1.61% or $0.11 reaching $6.71 on the news. About 605,207 shares traded. Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU) has risen 31.09% since November 6, 2016 and is uptrending. It has outperformed by 14.39% the S&P500.First Republic Investment Management Inc decreased its stake in Alexion Pharmaceuticals Inc (ALXN) by 65.28% based on its latest 2017Q2 regulatory filing with the SEC. First Republic Investment Management Inc sold 4,384 shares as the company’s stock declined 11.63% while stock markets rallied. The hedge fund held 2,332 shares of the health care company at the end of 2017Q2, valued at $284,000, down from 6,716 at the end of the previous reported quarter. First Republic Investment Management Inc who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be less bullish one the $25.89B market cap company. The stock declined 1.76% or $2.08 reaching $115.87 per share. About 721,684 shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since November 6, 2016 and is downtrending. It has underperformed by 34.82% the S&P500.Another recent and important Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU) news was published by Marketwatch.com which published an article titled: “Bank of Tokyo-Mitsubishi UFJ charged with spoofing in Treasury futures by CFTC” on August 07, 2017.Guardian Capital Advisors Lp, which manages about $1.66B and $695.43 million US Long portfolio, decreased its stake in Shaw Communications Inc (NYSE:SJR) by 12,055 shares to 36,659 shares, valued at $1.01M in 2017Q2, according to the filing. It also reduced its holding in Microsoft Corp (NASDAQ:MSFT) by 5,939 shares in the quarter, leaving it with 155,179 shares, and cut its stake in Corning Inc (NYSE:GLW). Among 3 analysts covering Mitsubishi UFJ Financial Group (NYSE:MTU), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Mitsubishi UFJ Financial Group had 5 analyst reports since August 17, 2015 according to SRatingsIntel. On Tuesday, February 21 the stock rating was upgraded by Citigroup to “Buy”. The rating was upgraded by UBS on Thursday, February 25 to “Buy”. The firm earned “Neutral” rating on Wednesday, November 23 by Goldman Sachs. Citigroup downgraded the stock to “Sell” rating in Thursday, February 4 report. Zacks upgraded Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU) rating on Monday, August 17. Zacks has “Hold” rating and $7.75 target.More notable recent Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) news were published by: Seekingalpha.com which released: “Alexion: Buy On Dips With Soliris Catalyst Upcoming” on October 08, 2017, also Streetinsider.com with their article: “Alexion Pharma (ALXN) Receives New Japanese Patent for Soliris” published on November 06, 2017, Nasdaq.com published: “Alexion Pharmaceuticals Inc. Profit Advances 17% In Q3” on October 26, 2017. More interesting news about Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) were released by: Seekingalpha.com and their article: “An In-Depth Look At Alexion’s Competition And Upcoming Catalysts” published on October 10, 2017 as well as Seekingalpha.com‘s news article titled: “Alexion Pharmaceuticals (ALXN) Q3 2017 Results – Earnings Call Transcript” with publication date: October 26, 2017.Among 28 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Alexion Pharmaceuticals Inc. had 86 analyst reports since July 27, 2015 according to SRatingsIntel. Oppenheimer maintained the shares of ALXN in report on Wednesday, June 14 with “Hold” rating. Morgan Stanley maintained Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) rating on Friday, July 28. Morgan Stanley has “Buy” rating and $15300 target. The rating was maintained by UBS on Friday, July 31 with “Buy”. The company was maintained on Thursday, July 27 by Cowen & Co. BMO Capital Markets maintained the shares of ALXN in report on Tuesday, June 13 with “Buy” rating. FBR Capital initiated the shares of ALXN in report on Thursday, September 15 with “Underperform” rating. The firm has “Hold” rating by Jefferies given on Friday, September 23. The firm has “Hold” rating given on Friday, June 23 by Robert W. Baird. The firm has “Buy” rating given on Friday, December 11 by Stifel Nicolaus. The firm has “Buy” rating given on Tuesday, September 20 by Citigroup.First Republic Investment Management Inc, which manages about $25.99B and $13.18 billion US Long portfolio, upped its stake in Ishares Tr (QUAL) by 12,868 shares to 330,616 shares, valued at $24.59 million in 2017Q2, according to the filing. It also increased its holding in Aetna Inc New (NYSE:AET) by 2,746 shares in the quarter, for a total of 56,948 shares, and has risen its stake in Valeant Pharmaceuticals Intl (NYSE:VRX). Investors sentiment increased to 1.37 in 2017 Q2. Its up 0.23, from 1.14 in 2017Q1. It improved, as 55 investors sold ALXN shares while 146 reduced holdings. 72 funds opened positions while 203 raised stakes. 208.01 million shares or 0.31% less from 208.67 million shares in 2017Q1 were reported. Farmers & Merchants owns 0% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 44 shares. Odey Asset Mngmt Grp Incorporated Limited has invested 0.27% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Blackrock Inc holds 19.93 million shares. Tower Cap Ltd Liability Company (Trc) owns 0.02% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 1,793 shares. Reilly Fincl Advisors Ltd Co reported 0% stake. 345,973 were accumulated by Asset One Company Ltd. Blair William And Il has invested 0.01% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). State Treasurer State Of Michigan invested in 0.34% or 373,778 shares. Samlyn Ltd Co accumulated 0.25% or 84,100 shares. Mariner Wealth Ltd Co holds 5,073 shares. Massachusetts-based Panagora Asset has invested 0% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). 15,000 are owned by Proxima Lc. Lpl Fin Limited Liability Company stated it has 0.01% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Gateway Invest Advisers Limited owns 0.17% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 154,531 shares. Veritable Lp stated it has 0.01% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN).Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
TRADE IDEAS REVIEW – IS THIS THE BEST STOCK SCANNER?

Trade Ideas is arguably one of the top scanning tools available on the market right

Trade Ideas Pro helps traders find the best setups in the market right NOW

Scottrade and E*TRADE license Trade Ideas proprietary technology for their premium trading platforms. We have fully automated trading available through Lightspeed and Interactive Brokers.Trade Ideas is the BEST Tool for Scanning. I would be LOST without Trade ideas. Ross Cameron – Warrior Trading